ProCE Banner Activity

Current Clinical Experience and New Therapeutic Directions for Second-line and Subsequent Lines of Therapy in Metastatic Urothelial Carcinoma

Slideset Download
Download this slideset from Matthew Milowsky, MD to review optimal treatment selection for patients with urothelial carcinoma and progression disease after previous therapy.

Released: June 22, 2020

Expiration: June 21, 2021

No longer available for credit.

Share

Faculty

Matthew I. Milowsky

Matthew I. Milowsky, MD

Professor of Medicine
Division of Hematology/Oncology
Department of Medicine
Lineberger Comprehensive Cancer Center
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Provided by

Provided by National Comprehensive Cancer Network.
ProCE Banner

Supporters

Supported by an independent educational grant from Merck & Co., Inc.

Supported by educational grants from

Astellas Seattle Genetics

QED Therapeutics

Faculty Disclosure

Primary Author

Matthew I. Milowsky, MD

Professor of Medicine
Division of Hematology/Oncology
Department of Medicine
Lineberger Comprehensive Cancer Center
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina